NCT06453408

Brief Summary

This study aims to validate a placebo dry needling protocol for patients with non-specific neck pain and investigate whether prior experience with dry needling affects their ability to distinguish between real and placebo treatments, and how this impacts outcomes. Seventy participants aged 18-65 will be recruited and divided into two groups based on their previous dry needling experience, then randomized into real or placebo needling groups. Assessment will be carried out before treatment, immediately after the procedure and one week later. Pain intensity, pain threshold to pressure, cervical range of motion, level of disability and presence of central sensitisation will also be measured.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2024

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 5, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 11, 2024

Completed
14 days until next milestone

Study Start

First participant enrolled

June 25, 2024

Completed
6 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2024

Completed
Last Updated

June 11, 2024

Status Verified

June 1, 2024

Enrollment Period

6 days

First QC Date

June 5, 2024

Last Update Submit

June 5, 2024

Conditions

Keywords

dry needlingvalidationplaceboneck pain

Outcome Measures

Primary Outcomes (1)

  • Successful identification rate of group assignment

    A Questionnaire of its own, designed to record participants' perceptions of the perceived intervention, will be used. Participants will be asked to select which group they believe they belong to by choosing one of five possible responses: 1. I strongly believe I was assigned to the treatment group. 2. I believe to some extent that I was assigned to the treatment group. 3. I believe to some extent that I was assigned to the control group. 4. I strongly believe that I was assigned to the control group. 5. I am not sure

    Immediately after the intervention and one week later, in order to see if any participants change their response.

Secondary Outcomes (5)

  • Pain intensity

    Before and immediately after the intervention, and a new assessment will be carried out one week later.

  • Neck disability

    Before and one week after the intervention.

  • Cervical Range of Motion

    Before intervention, immediately after intervention and after one week.

  • central sensitisation

    Before the intervention and one week after

  • Pressure pain threshold

    Before the intervention, immediately after the intervention and one week afterwards

Study Arms (4)

Placebo, sin experiencia

SHAM COMPARATOR

Group of patients with no previous experience in dry needling, will be given placebo dry needling

Procedure: Punción seca con aguja retráctil

Placebo, con experiencia

SHAM COMPARATOR

Group of patients with previous experience in dry needling, will be given placebo dry needling

Procedure: Punción seca con aguja retráctil

Real, sin experiencia

EXPERIMENTAL

Group of patients with no previous experience in dry needling, real dry needling will be applied

Procedure: Punción seca con aguja normativa.

Real, con experiencia

EXPERIMENTAL

Group of patients with previous experience in dry needling, real dry needling will be applied.

Procedure: Punción seca con aguja normativa.

Interventions

The placebo dry needling protocol will be performed in the same position, with identical antiseptic measures and the same number of simulated incisions as the real dry needling protocol, using DONGBANG AcuPrime® 0.30 x 30mm blunt-tipped placebo needles with a retractable handle. These needles simulate the sensation of needle contact without penetrating the skin. The therapist will hold the needle and guide tube, pressing the tube against the skin and simulating needle manipulation. Changes in pressure direction will mimic the real technique. The protocol will end with compression using an alcohol swab and an upper trapezius stretch. Participants in both groups will receive the same information about the sensations of the dry needling procedure. At the beginning, they will be informed that they may or may not feel the needle insertion. They will also be told that the physiotherapist will manually manipulate the needle multiple times during the procedure.

Also known as: DONGBANG AcuPrime® de 0,30 x 30mm.
Placebo, con experienciaPlacebo, sin experiencia

To perform the actual SP, patients shall be asked to lie prone with arms close to the body. The dry needling shall be performed with a 0,30 × 30 mm DN needle (APS Regular Agupunt) with a guide tube. The therapist shall first clean the area with alcohol. The trapezius muscle is then firmly grasped with a clamp between the thumb and index finger, so that the needle is directed deep into the index finger until the tip of the needle is felt to be approaching (33). This procedure involves an approximate insertion of the needle to a depth of 30 mm and ensures the intramuscular penetration necessary for dry needling. Puncture of the PGM shall be performed using the Hong technique (34), performing up to 12 inlets and outlets, at a frequency of 1 Hz. When the needle is withdrawn, the area is firmly compressed with cotton wool for 60 seconds. Finally, the upper trapezius muscle is stretched, following the technique originally described by Simons (35).

Also known as: APS Regular Agupunt 0,30 × 30 mm
Real, con experienciaReal, sin experiencia

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Non-specific neck pain, unilateral or bilateral.
  • Neck pain lasting ≥ 3 months.
  • Presence of active myofascial trigger point (MTrP) in the upper trapezius muscle, left, right or bilateral, in relation to the patient's neck pain.

You may not qualify if:

  • Fear or phobia of needles
  • Skin lesions, infection or inflammation in the area to be pricked
  • Specific alterations of the cervical region in the medical history
  • Coagulation disorders
  • Surgical intervention of the cervical or anterior shoulder region
  • Undergoing pharmacological treatment with analgesics, anti-inflammatory drugs or anticoagulants in the week prior to the study.
  • Having received physiotherapy treatment in the neck region in the 6 months prior to the intervention.
  • Infiltration of corticosteroids or local anaesthetics up to one year prior to the study.
  • Cognitive deficits in the medical history.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (10)

  • Pariente J, White P, Frackowiak RS, Lewith G. Expectancy and belief modulate the neuronal substrates of pain treated by acupuncture. Neuroimage. 2005 May 1;25(4):1161-7. doi: 10.1016/j.neuroimage.2005.01.016.

    PMID: 15850733BACKGROUND
  • Bier JD, Scholten-Peeters WGM, Staal JB, Pool J, van Tulder MW, Beekman E, Knoop J, Meerhoff G, Verhagen AP. Clinical Practice Guideline for Physical Therapy Assessment and Treatment in Patients With Nonspecific Neck Pain. Phys Ther. 2018 Mar 1;98(3):162-171. doi: 10.1093/ptj/pzx118.

    PMID: 29228289BACKGROUND
  • Boonstra AM, Schiphorst Preuper HR, Reneman MF, Posthumus JB, Stewart RE. Reliability and validity of the visual analogue scale for disability in patients with chronic musculoskeletal pain. Int J Rehabil Res. 2008 Jun;31(2):165-9. doi: 10.1097/MRR.0b013e3282fc0f93.

    PMID: 18467932BACKGROUND
  • Andrade Ortega JA, Delgado Martinez AD, Almecija Ruiz R. [Validation of a Spanish version of the Neck Disability Index]. Med Clin (Barc). 2008 Feb 2;130(3):85-9. doi: 10.1157/13115352. Spanish.

    PMID: 18261377BACKGROUND
  • Cuesta-Vargas AI, Roldan-Jimenez C, Neblett R, Gatchel RJ. Cross-cultural adaptation and validity of the Spanish central sensitization inventory. Springerplus. 2016 Oct 21;5(1):1837. doi: 10.1186/s40064-016-3515-4. eCollection 2016.

    PMID: 27818875BACKGROUND
  • Baldry P. Superficial versus deep dry needling. Acupunct Med. 2002 Aug;20(2-3):78-81. doi: 10.1136/aim.20.2-3.78.

    PMID: 12216605BACKGROUND
  • Hafliethadottir SH, Juhl CB, Nielsen SM, Henriksen M, Harris IA, Bliddal H, Christensen R. Placebo response and effect in randomized clinical trials: meta-research with focus on contextual effects. Trials. 2021 Jul 26;22(1):493. doi: 10.1186/s13063-021-05454-8.

    PMID: 34311793BACKGROUND
  • Birch S. A review and analysis of placebo treatments, placebo effects, and placebo controls in trials of medical procedures when sham is not inert. J Altern Complement Med. 2006 Apr;12(3):303-10. doi: 10.1089/acm.2006.12.303.

    PMID: 16646730BACKGROUND
  • Bang H, Ni L, Davis CE. Assessment of blinding in clinical trials. Control Clin Trials. 2004 Apr;25(2):143-56. doi: 10.1016/j.cct.2003.10.016.

    PMID: 15020033BACKGROUND
  • Rodriguez-Huguet M, Vinolo-Gil MJ, Gongora-Rodriguez J. Dry Needling in Physical Therapy Treatment of Chronic Neck Pain: Systematic Review. J Clin Med. 2022 Apr 23;11(9):2370. doi: 10.3390/jcm11092370.

    PMID: 35566496BACKGROUND

MeSH Terms

Conditions

Neck Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Leire Vazquez-Casar

    University of Alcala

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Leire Vazquez-Casar

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Leire Vázquez Casar

Study Record Dates

First Submitted

June 5, 2024

First Posted

June 11, 2024

Study Start

June 25, 2024

Primary Completion

July 1, 2024

Study Completion

October 1, 2024

Last Updated

June 11, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share